Aclarion Inc (ACON)vsHinge Health, Inc. (HNGE)
ACON
Aclarion Inc
$1.74
-1.14%
HEALTHCARE · Cap: $5.62M
HNGE
Hinge Health, Inc.
$120.91
+3.45%
HEALTHCARE · Cap: $9.43B
Smart Verdict
WallStSmart Research — data-driven comparison
Hinge Health, Inc. generates 859469% more annual revenue ($720.06M vs $83,770). HNGE leads profitability with a 15.1% profit margin vs 0.0%. HNGE earns a higher WallStSmart Score of 52/100 (C-).
ACON
Avoid33
out of 100
Grade: F
HNGE
Buy52
out of 100
Grade: C-
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 30.5% year-over-year
Revenue surging 53.0% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Premium valuation, high expectations priced in
Weak financial health signals
Trading at 28.2x book value
ROE of -197.2% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ACON
The strongest argument for ACON centers on Price/Book, Revenue Growth. Revenue growth of 30.5% demonstrates continued momentum.
Bull Case : HNGE
The strongest argument for HNGE centers on Revenue Growth, Debt/Equity. Profitability is solid with margins at 15.1% and operating margin at 19.0%. Revenue growth of 53.0% demonstrates continued momentum.
Bear Case : ACON
The primary concerns for ACON are EPS Growth, Market Cap, Profit Margin.
Bear Case : HNGE
The primary concerns for HNGE are P/E Ratio, Piotroski F-Score, Price/Book.
Key Dynamics to Monitor
ACON profiles as a hypergrowth stock while HNGE is a growth play — different risk/reward profiles.
HNGE is growing revenue faster at 53.0% — sustainability is the question.
HNGE generates stronger free cash flow (100M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
HNGE scores higher overall (52/100 vs 33/100), backed by strong 15.1% margins and 53.0% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Aclarion Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Aclarion Inc (ACON) is an innovative healthcare technology company focused on transforming the diagnosis and management of musculoskeletal conditions through advanced non-invasive imaging and data analytics. Leveraging machine learning capabilities, Aclarion provides healthcare professionals with actionable insights that improve clinical outcomes while optimizing cost-effective treatment pathways. As a key player in the digital health arena, the company is positioned to address the growing demand for effective diagnostic solutions, thereby enhancing patient care and management in a rapidly evolving healthcare environment. Aclarion's commitment to improving patient outcomes places it at the forefront of future healthcare delivery advancements.
Visit Website →Hinge Health, Inc.
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?